Literature DB >> 7867603

Induction of classical lactotropes by epidermal growth factor in rat pituitary cell cultures.

R Felix1, U Meza, G Cota.   

Abstract

Long term incubation of pituitary tumor GH3 cultures with epidermal growth factor (EGF) induces reciprocal changes in PRL and GH production. However, it is not known whether EGF alters the cellular composition of these cultures. Another unanswered question is whether chronic treatment with EGF stimulates PRL secretion from nonneoplastic pituitary cells. In this study, GH3 cells and pituitary cells from neonatal (10-day-old) rats were cultured for 6 and 2 days, respectively, in the absence or presence of 5 nM EGF. Cells containing PRL and/or GH were then enumerated using light microscopic immunocytochemistry. In addition, neonatal pituitary cells were subjected to reverse hemolytic plaque assays for PRL. EGF treatment drastically increased the proportion of classical lactotropes (cells that secrete only PRL) in the GH3 cultures, from about 0.5% to 8% of all cells, without modifying the percentage of GH-positive cells. A similar action of EGF was observed in the primary cultures. Moreover, EGF enhanced by 240% the amount of PRL secreted from the neonatal lactotrope population during 1-h incubations under basal conditions. This effect was mediated by a selective increase in the relative number of PRL secretors forming large plaques. The results suggest that EGF promotes the differentiation of classical lactotropes in both GH3 cultures and pituitary cultures from neonatal rats, and that these cells are characterized by a high basal rate of PRL secretion.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7867603     DOI: 10.1210/endo.136.3.7867603

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  17 in total

1.  Persistent ERK/MAPK activation promotes lactotrope differentiation and diminishes tumorigenic phenotype.

Authors:  Allyson Booth; Tammy Trudeau; Crystal Gomez; M Scott Lucia; Arthur Gutierrez-Hartmann
Journal:  Mol Endocrinol       Date:  2014-12

Review 2.  Paracrinicity: the story of 30 years of cellular pituitary crosstalk.

Authors:  C Denef
Journal:  J Neuroendocrinol       Date:  2008-01       Impact factor: 3.627

3.  Rat prolactinoma cell growth regulation by epidermal growth factor receptor ligands.

Authors:  George Vlotides; Emily Siegel; Ines Donangelo; Shiri Gutman; Song-Guang Ren; Shlomo Melmed
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

Review 4.  Growth factors in the pathogenesis of prolactin-secreting tumors.

Authors:  C Missale; P F Spano
Journal:  J Endocrinol Invest       Date:  1998-06       Impact factor: 4.256

Review 5.  Expression and function of ErbB receptors and ligands in the pituitary.

Authors:  Odelia Cooper; George Vlotides; Hidenori Fukuoka; Mark I Greene; Shlomo Melmed
Journal:  Endocr Relat Cancer       Date:  2011-10-27       Impact factor: 5.678

6.  Fibroblast growth factor-2 and epidermal growth factor modulate prolactin responses to TRH and dopamine in primary cultures.

Authors:  Carlos Spuch; Yolanda Diz-Chaves; Diego Pérez-Tilve; Federico Mallo
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

7.  p90 RSK-1 associates with and inhibits neuronal nitric oxide synthase.

Authors:  Tao Song; Katsuyoshi Sugimoto; Hideshi Ihara; Akihiro Mizutani; Naoya Hatano; Kodai Kume; Toshie Kambe; Fuminori Yamaguchi; Masaaki Tokuda; Yasuo Watanabe
Journal:  Biochem J       Date:  2007-01-15       Impact factor: 3.857

8.  Lack of prolactin receptor signaling in mice results in lactotroph proliferation and prolactinomas by dopamine-dependent and -independent mechanisms.

Authors:  Kathryn G Schuff; Shane T Hentges; Michele A Kelly; Nadine Binart; Paul A Kelly; P Michael Iuvone; Sylvia L Asa; Malcolm J Low
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

9.  ErbB receptor-driven prolactinomas respond to targeted lapatinib treatment in female transgenic mice.

Authors:  Xiaohai Liu; Maya Kano; Takako Araki; Odelia Cooper; Hidenori Fukuoka; Yukiko Tone; Masahide Tone; Shlomo Melmed
Journal:  Endocrinology       Date:  2015-01       Impact factor: 4.736

10.  Epidermal growth factor triggers an original, caspase-independent pituitary cell death with heterogeneous phenotype.

Authors:  Joanna Fombonne; Stéphanie Reix; Ramahefarizo Rasolonjanahary; Emmanuelle Danty; Sylvie Thirion; Geneviéve Laforge-Anglade; Olivier Bosler; Patrick Mehlen; Alain Enjalbert; Slavica Krantic
Journal:  Mol Biol Cell       Date:  2004-08-25       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.